← Leaderboards
Aimee Kreimer
Division Of Cancer Epidemiology And Genetics
$0
Attributed
$0
Total exposure
0
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
—
By mechanism
—
Top collaborators
No co-investigators on record.
Most similar at Division Of Cancer Epidemiology And Genetics
Same institution · by research overlap
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsHuman PapillomavirusCervicalEvaluationMalignant Neoplasm Of Cervix UteriInfectionNatural HistoryHead And Neck CancerHuman Papilloma Virus InfectionSiteAnusHuman Papillomavirus 16Cervix UteriCytologyHuman Papilloma Virus-Related Malignant NeoplasmTumorVaccine TrialVaginaGenotypeOropharyngealDiagnosisMultiple Anatomic SitesPenisCohort
Grant awards (27)
HPV Vaccine Trial$1,793,621
ZIA · FY2025 · CA · contact PI
HPV, cervical neoplasia, and vaccination$100,152
ZIA · FY2025 · CA · contact PI
HPV and cancer at multiple anatomic sites$62,529
ZIA · FY2025 · CA · contact PI
HPV Vaccine Trial$3,625,989
ZIA · FY2024 · CA · contact PI
HPV and cancer at multiple anatomic sites$507,330
ZIA · FY2024 · CA · contact PI
HPV, cervical neoplasia, and vaccination$440,267
ZIA · FY2024 · CA · contact PI
Evaluating Differences in HPV Attributable Fraction and Genotype Distribution in Cervical, Anal, Genital, and Oropharyngeal Cancers among People with and without HIV infection in South Africa$318,012
ZIA · FY2024 · CA · contact PI
HPV Vaccine Trial$3,700,411
ZIA · FY2023 · CA · contact PI
HPV and cancer at multiple anatomic sites$512,360
ZIA · FY2023 · CA · contact PI
HPV, cervical neoplasia, and vaccination$461,995
ZIA · FY2023 · CA · contact PI
HPV Vaccine Trial$9,094,976
ZIA · FY2022 · CA · contact PI
HPV and cancer at multiple anatomic sites$526,734
ZIA · FY2022 · CA · contact PI
HPV, cervical neoplasia, and vaccination$125,787
ZIA · FY2022 · CA · contact PI
HPV and cancer at multiple anatomic sites$462,179
ZIA · FY2021 · CA · contact PI
HPV, cervical neoplasia, and vaccination$365,490
ZIA · FY2021 · CA · contact PI
HPV Vaccine Trial$69,426
ZIA · FY2021 · CA · contact PI
HPV and cancer at multiple anatomic sites$406,552
ZIA · FY2020 · CA · contact PI
HPV and cancer at multiple anatomic sites$70,959
ZIA · FY2019 · CA · contact PI
HPV and cancer at multiple anatomic sites$105,647
ZIA · FY2018 · CA · contact PI
HPV and cancer at multiple anatomic sites$94,630
ZIA · FY2017 · CA · contact PI
HPV and cancer at multiple anatomic sites$427,521
ZIA · FY2016 · CA · contact PI
HPV and cancer at multiple anatomic sites$617,212
ZIA · FY2015 · CA · contact PI
HPV and cancer at multiple anatomic sites$837,996
ZIA · FY2014 · CA · contact PI
HPV and cancer at multiple anatomic sites$568,151
ZIA · FY2013 · CA · contact PI
HPV and cancer at multiple anatomic sites$998,319
ZIA · FY2012 · CA · contact PI
HPV and cancer at multiple anatomic sites$1,260,717
ZIA · FY2011 · CA · contact PI
HPV and cancer at multiple anatomic sites$473,294
ZIA · FY2010 · CA · contact PI